Genevieve's Journey: Cannabis and Dentistry for the Developmentally Disabled
Art Courtesy of Casey Renteria
Genevieve's Transformative Journey with Cannabinoid Medicine
Understanding the Power of Cannabinoid Medicine
When I first came into Genevieve's life, there were none of the smiles and laughter that so many have become used to seeing from this young lady who loves her Carousel rides. In the beginning of our relationship, she was another compassion patient I set out to help.
Like so many others around the nation, Genevieve's mother contacted me about the Compassionate Care program I ran, providing free and pure oils to those in need.
How it Started: The Heartwarming Encounter with Genevieve and Anne Mari
I met Genevieve and her mom, Anne Mari, when she had just turned 13. When I found this child in need, I had no plans of creating a family or anything other than bringing oil to the child in need. But, I found myself adopting love when it came to Genevieve, as it adopted me.
Photos Courtesy of Author
Navigating Challenges: Autism, Seizures, and Epilepsy
Today, we offer a nuanced perspective into the specific cannabinoids that benefit Genevieve, especially as she faces the challenges of upcoming oral surgery. This type of surgery is not usually easy for people with severe developmental delays.
Genevieve was diagnosed with Autism at a very young age and started having seizures when she was only two years old.
It took another decade of maneuvering through Western Medicine for Genevieve to obtain an Epilepsy diagnosis as well.
Innovative Approaches: Plant Medicine and Dental Experience
To ensure continuity in Genevieves’ plant medicine regimen, innovative approaches like infusing cannabinoids into gelatin-based desserts and soft foods must lead to a positive experience with the dentist she dislikes.
It takes profound amounts of sedation to get her into that dentist chair, and then she must use the gas. She often will also take a nap while the professionals work. THC and CBD were particularly effective for her, whereas CBD initially did not yield the desired results.
Exploring Cannabinoids: THCA, THC, and CBN Regimen
Historically, during the initial stages of seizure control and cognitive enhancement, Genevieve primarily benefited from a regimen containing THCA, THC, and CBN housed within an MCT infusion.
This blend preserved the organic plant components, ensured the presence of vital terpenes, and also included flavonoids that are often missing in refined oils. THC and CBN were particularly effective for her, whereas CBD initially did not yield the desired results.
Unveiling the Role of CBGa: A Game-Changing Cannabinoid
This issue led to the incorporation of CBGa, positioning Genevieve as an emblematic case of an autistic child benefiting from this primary acidic cannabinoid common to all cannabis strains.
When we first met, when the Cannabis Love Story family just began in 2016, very few knew what the cannabinoid was, so I had to call it CBG.
She used it for quite some time, and then we slowly backed off, but I kept researching.
Shaping the Future: CBGa Tincture and Genevieve's Dream
As Genevieve's metabolic responses evolved and her tolerance to the THC/CBN combination increased, I began to start leveraging insights from my work at the Global Cannabinoid Research Center. I reintroduced CBGa at this time into her regimen.
Embracing Minor Cannabinoids for Holistic Wellness
Recent insights from Oregon State University have illuminated the significance of acidic cannabinoids, notably CBGa, in promoting a deeper understanding of its potential in Cannabis Science.
Many consumers also wanted to know more about it, and our long-lived plan to create Genevieve's Dream, a CBGa Tincture, began to take root by the sharing of this information our family had discovered.
Cultivating Endocannabinoid Tone: CBG, CBDa, and More
While addressing Genevieves’ body's saturation from major cannabinoids, the focus shifted towards minor cannabinoids. Innovative solutions, including transdermal delivery mechanisms infused with hemp-derived nanotechnology-crafted minor cannabinoids (CBGa, CBG, CBDa, and others), became pivotal in our journey.
By incorporating these minor cannabinoids into her therapeutic baths, they proved themselves invaluable. They were stimulating endocannabinoid production, which is a critical component for overall system balance when working with cannabis patients.
Research substantiates that consuming minor cannabinoids, coupled with a wholesome diet and physical activity, augments the production of endogenous cannabinoids, which THC emulates.
This facilitates the growth of new CB1 receptors, essential for recalibrating the endocannabinoid system, which is exactly what Genevieve needed.
Individuality Matters: Genevieve's Unique Cannabinoid Response
The prevalent misconception that CBGa and CBD do not engage with cannabinoid receptors is slowly fading as the world gains more insight into the plant and how it works in the body.
My research findings underscore the role of minor cannabinoids, terpenes, and phytonutrients in significantly enhancing endocannabinoid tone - and found that CBGa as the precursor molecule in the plant is indeed a Major Cannabinoid.
Without CBGa, we would not have THCa, CBCa, CBDa, which all produce quite a few cannabinoids themselves, and of course, CBGa, when heated, makes CBG. The number of this natural propensity amplifies receptor presence, ensuring system balance.
Empowering the Future: Genevieve's Autonomy with CBGa
With CBGa as the cornerstone, our aspirations for Genevieve's autonomy get renewed, establishing new milestones for her as previous ones get achieved. The evolving landscape of
healthcare indicates a shift towards plant-based treatments, with cases like Genevieve's exemplifying their efficacy.
Revolutionizing Healthcare: Nature's Synergy with Well-Being
Half a decade ago, Genevieve was prescribed a potent pharmaceutical cocktail often associated with psychiatric treatments. By disseminating this knowledge, I'm hopeful that patients and practitioners will recognize alternative therapeutic pathways, transcending the traditional confines of prescription-based treatments and reinvigorating the fundamental medical principle: Primum non nocere (first, do no harm).
Our Collective Responsibility: Advocating for Superior Healthcare
I harnessed these revelations, mainly the rapid endocannabinoid-driven receptor growth, which has been instrumental in mitigating behavioral challenges Genevieve faced due to external environmental constraints in the pandemic and helped her reduce inflammation and discomfort in issues like her dental.
Her evolving relationship with CBGa, characterized by its oral administration, exemplifies her growing repertoire of cannabinoids. By employing terpenes sourced from cannabis, hemp, and botanicals, particularly for transdermal applications, further accentuates her holistic treatment, leading to outstanding outcomes.
Genevieve's story resonates with many, yet it is imperative to appreciate individual physiological differences in cannabinoid response.
Our collective responsibility is to advocate for superior healthcare solutions, recognizing the undeniable synergy between nature's offerings and human well-being.
Genevieve's journey, documented by millions globally, is a testament to the transformative power of cannabinoid medicine on cognitive progression. Learn more and connect with Mike online via the following:
The full story of this amazing family here
Mike Robinson on LinkedIn here
The future of CBGa: Genevieve's Dream here
